Unknown

Dataset Information

0

Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival.


ABSTRACT: AIMS:Many heart transplant recipients will develop end-stage renal disease in the post-operative course. The aim of this study was to identify the long-term incidence of end-stage renal disease, determine its risk factors, and investigate what subsequent therapy was associated with the best survival. METHODS AND RESULTS:A retrospective, single-centre study was performed in all adult heart transplant patients from 1984 to 2016. Risk factors for end-stage renal disease were analysed by means of multivariable regression analysis and survival by means of Kaplan-Meier. Of 685 heart transplant recipients, 71 were excluded: 64 were under 18 years of age and seven were re-transplantations. During a median follow-up of 8.6 years, 121 (19.7%) patients developed end-stage renal disease: 22 received conservative therapy, 80 were treated with dialysis (46 haemodialysis and 34 peritoneal dialysis), and 19 received a kidney transplant. Development of end-stage renal disease (examined as a time-dependent variable) inferred a hazard ratio of 6.45 (95% confidence interval 4.87-8.54, P < 0.001) for mortality. Tacrolimus-based therapy decreased, and acute kidney injury requiring renal replacement therapy increased the risk for end-stage renal disease development (hazard ratio 0.40, 95% confidence interval 0.26-0.62, P < 0.001, and hazard ratio 4.18, 95% confidence interval 2.30-7.59, P < 0.001, respectively). Kidney transplantation was associated with the best median survival compared with dialysis or conservative therapy: 6.4 vs. 2.2 vs. 0.3 years (P < 0.0001), respectively, after end-stage renal disease development. CONCLUSIONS:End-stage renal disease is a frequent complication after heart transplant and is associated with poor survival. Kidney transplantation resulted in the longest survival of patients with end-stage renal disease.

SUBMITTER: Roest S 

PROVIDER: S-EPMC7160492 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival.

Roest Stefan S   Hesselink Dennis A DA   Klimczak-Tomaniak Dominika D   Kardys Isabella I   Caliskan Kadir K   Brugts Jasper J JJ   Maat Alexander P W M APWM   Ciszek Michał M   Constantinescu Alina A AA   Manintveld Olivier C OC  

ESC heart failure 20200205 2


<h4>Aims</h4>Many heart transplant recipients will develop end-stage renal disease in the post-operative course. The aim of this study was to identify the long-term incidence of end-stage renal disease, determine its risk factors, and investigate what subsequent therapy was associated with the best survival.<h4>Methods and results</h4>A retrospective, single-centre study was performed in all adult heart transplant patients from 1984 to 2016. Risk factors for end-stage renal disease were analysed  ...[more]

Similar Datasets

| S-EPMC5880747 | biostudies-literature
| S-EPMC4833352 | biostudies-other
| S-EPMC6023765 | biostudies-literature
| S-EPMC3344899 | biostudies-literature
| S-EPMC7053372 | biostudies-literature
| S-EPMC8017003 | biostudies-literature
| S-EPMC6323519 | biostudies-literature
| S-EPMC3470642 | biostudies-literature
| S-EPMC3758352 | biostudies-literature
| S-EPMC4788810 | biostudies-literature